A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.40892
PubMed Identifier: 30983166
Publication URI: http://europepmc.org/abstract/MED/30983166
Type: Journal Article/Review
Volume: 71
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 9
ISSN: 2326-5191